The Association Between Fever and CDKL5 Deficiency Disorder: a Nationwide Survey
1 other identifier
observational
131
1 country
1
Brief Summary
The primary objective of this research is to study the effects of fever on seizure activity in patients with CDKL5 deficiency disorder
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 27, 2024
CompletedFirst Posted
Study publicly available on registry
October 29, 2024
CompletedStudy Start
First participant enrolled
October 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedApril 14, 2026
April 1, 2026
2 months
October 27, 2024
April 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Seizure frequency
The results of seizure reduction reported in the questionnaire completed by the parents or the seizure diary provided online
Fever episodes within one year leading up to 2 hours of questionnaire completion
Interventions
This study was an observational study without intervention
Eligibility Criteria
Male or female children with a diagnosis of CDKL5 deficiency, including molecular confirmation of a pathogenic or likely pathogenic CDKL5 variant and refractory seizures.
You may qualify if:
- A diagnosis of CDKL5 deficiency, including molecular confirmation of a pathogenic or likely pathogenic CDKL5 variant and refractory seizures.
- Parents or guardians are willing to complete and provide information about the child's medical history and fever history after receiving the survey questionnaire online.
You may not qualify if:
- Any history of previous brain disease (trauma, etc.) that likely to precipitate seizures.
- Presence of any clinical condition that in the opinion of the principal investigator makes the patient not suitable to participate in the trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Xuanwu Hospital,Capital Medical University
Beijing, Beijing Municipality, 100053, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Liankun Ren, MD
Xuanwu Hospital, Beijing
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 27, 2024
First Posted
October 29, 2024
Study Start
October 29, 2024
Primary Completion
December 15, 2024
Study Completion
December 31, 2024
Last Updated
April 14, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share